Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions

European Journal of Pharmaceutical Sciences

Volumn 71, Issue , 2015, Pages 12-24

  Meng, Fan ^a   Trivino, Anne ^a   Prasad, Dev ^b   Chauhan, Harsh ^a  

^a CREIGHTON UNIVERSITY   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Amorphous; Curcumin; Miscibility; Molecular interactions Polymers; Solid dispersion

Indexed keywords

CURCUMIN; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 8000; POVIDONE; POLYMER;

ARTICLE; CHEMICAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DISSOLUTION; DRUG SOLUBILITY; EVAPORATION; GLASS TRANSITION TEMPERATURE; HYDROGEN BOND; INFRARED SPECTROSCOPY; MELTING POINT; MISCIBILITY; MOLECULAR INTERACTION; MOLECULAR MODEL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; THERMOGRAVIMETRY; X RAY DIFFRACTION; CHEMISTRY; DRUG FORMULATION; SOLUBILITY; TRANSITION TEMPERATURE;

CURCUMIN; DRUG COMPOUNDING; MODELS, MOLECULAR; POLYMERS; SOLUBILITY; THERMOGRAVIMETRY; TRANSITION TEMPERATURE; X-RAY DIFFRACTION;

EID: 84923369397     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2015.02.003     Document Type: Article

References (42)

1. B.B. Aggarwal, and K.B. Harikumar Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Int. J. Biochem. Cell Biol. 41 2009 40 59
2. G.P. Andrews, O.A. Abudiak, and D.S. Ones Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions J. Pharm. Sci. 99 2010 1322 1335
3. W.L. Archer Hansen solubility parameters for selected cellulose ether derivatives and their use in the pharmaceutical industry Drug Develop. Ind. Pharm. 18 1992 599 616
4. G. Arun, P. Shweta, and K.J. Upendra Formulation and evaluation of ternary solid dispersion of curcumin Int. J. Pharm. Pharm. Sci. 4 2012 360 365
5. S. Azarmi, W. Roa, and R. Lobenberg Current perspectives in dissolution testing of conventional and novel dosage forms Int. J. Pharm. 328 2007 12 21
6. J.A. Baird, and L.S. Taylor Evaluation of amorphous solid dispersion properties using thermal analysis techniques Adv. Drug Deliv. Rev. 64 2012 96 421
7. J.A. Baird, B. Van Eerdenbrugh, and L.S. Taylor A classification system to assess the crystallization tendency of organic molecules from undercooled melts J. Pharm. Sci. 99 9 2010 3787 3806
8. H. Chauhan, C.H. Gu, and E. Atef Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions J. Pharm. Sci. 102 6 2013 1924 1935
9. H. Chauhan, A. Kuldipkumar, T. Barder, A. Medek, C.H. Gu, and E. Atef Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction Pharm. Res. 31 2014 500 515
10. R.J. Chokshi, H.K. Sandhu, R.M. Iyer, N.H. Shah, A.W. Malick, and H. Zia Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion process as a means to manufacture solid dispersion/solution J. Pharm. Sci. 94 2005 2463 2474
11. D.Q.M. Craig The mechanisms of drug release from solid dispersions in water-soluble polymers Int. J. Pharm. 231 2002 131 144
12. A.N. Ghebremeskel, C. Vemavarapu, and M. Lodaya Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability Int. J. Pharm. 328 2007 119 129
13. D.J. Greenhalgh, A.C. Williams, P. Timmins, and P. York Solubility parameters as predictors of miscibility in solid dispersions J. Pharm. Sci. 88 1999 1182 1190
14. J. Gupta, C. Nunes, S. Vyas, and S. Jonnalagadda Prediction of solubility parameters and miscibility of pharmaceutical compounds by molecular dynamics simulations J. Phys. Chem. B 115 2011 2014 2023
15. B.C. Hancock, P. York, and R.C. Rowe The use of solubility parameters in pharmaceutical dosage form design Int. J. Pharm. 148 1997 1 21
16. I. Ivanisevic, S. Bates, and P. Chen Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions J. Pharm. Sci. 98 9 2009 3373 3386
17. K. Khougaz, and S.D. Clas Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers J. Pharm. Sci. 89 2000 1325 1334
18. K. Kogermann, A. Penkina, K. Predbannikova, K. Jeeger, P. Veski, J. Rantanen, and K. Naelapaa Dissolution testing of amorphous solid dispersions Int. J. Pharm. 444 2013 40 46
19. A.A.N. Lima, J.L. Soares-sobrinho, J.L. Silva, R.A.C. Correa-Junior, M.A.M. Lyra, F.L.A. Santos, B.G. Oliveira, M.Z. Hernandes, L.A. Rolim, and P.J. Rolim-Neto The use of solid dispersion systems in hydrophilic carriers to increase benznidazole solubility J. Pharm. Sci. 100 6 2011 2443 2451
20. T.P. Lodge, E.R. Wood, and J.C. Haley Two calorimetric glass transitions do not necessarily indicate immiscibility: the case of PEO/PMMA J. Polym. Sci. 44 2005 756 763
21. P.J. Marsac, S.L. Shamblin, and L.S. Taylor Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility Pharm. Res. 23 2006 2417 2426
22. P.J. Marsac, H. Konno, and L.S. Taylor A comparison of the physical stability of amorphous felodipine and nifedipine systems Pharm. Res. 23 10 2006 2306 2316
23. P.J. Marsac, T. Li, and L.S. Taylor Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters Pharm. Res. 26 1 2009 139 151
24. E. Meaurio, E. Zuza, and J.R. Sarasua Miscibility and specific interactions in blends of poly(l-lactide) with poly(vinylphenol) Macromolecules 38 2005 1207 1215
25. D.A. Miller, J.C. DiNunzio, W. Yang, J.W. McGinity, and R.O. Williams III Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption Pharm. Res. 25 2008 1450 1459
26. R.I. Moustafine, I.M. Zaharov, and V.A. Kemenova Physicochemical characterization and drug release properties of Eudragit EPO/Eudragit L 100-55 interpolyelectrolyte complexes Eur. J. Pharm. Sci. 63 2006 26 36
27. A. Newman, D. Engers, S. Bates, I. Ivanisevic, and R.C. Kelly Characterization of amorphous API: polymer mixtures using X-ray powder diffraction J. Pharm. Sci. 97 11 2008 4840 4856
28. S. Okonogi, T. Oguchi, E. Yonemochi, S. Puttipipatkhachorn, and K. Yamamoto Improved dissolution of ofloxacin via solid dispersion Int. J. Pharm. 156 1997 175 180
29. R. Panakati, and A.S. Narang Impact of excipient interaction on drug bioavailability from solid dosage form Exp. Rev. 29 2012 2639 2659
30. D. Prasad, H. Chauhan, and E. Atef Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects J. Pharm. Sci. 103 11 2014 3511 3523
31. Rowe, R.J., Sheskey, P.J., Quinn, M.E., 2009. Handbook of Pharmaceutical Excipients, sixth ed.
32. A.C.F. Rumondor, I. Ivanisevic, S. Bates, D.E. Alonzo, and L.S. Taylor Evaluation of drug-polymer miscibility in amorphous solid dispersion systems Pharm. Res. 26 2009 2523 2534
33. A.L. Sarode, H. Sandhu, N. Shah, W. Malick, and H. Zia Hot melt extrusion for amorphous solid dispersions: temperature and moisture activated drug-polymer interactions for enhanced stability Mol. Pharm. 10 2013 3665 3675
34. A.L. Sarode, H. Sandhu, N. Shah, W. Malick, and H. Zia Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation Eur. J. Pharm. Sci. 48 2013 371 384
35. A. Szuts, P. Lang, R. Ambrus, L. Kiss, M.A. Deli, and P. Szabó-Révész Applicability of sucrose laurate as surfactant in solid dispersions prepared by melt technology Int. J. Pharm. 410 2011 107 110
36. G. Terife, P. Wang, N. Faridi, and C.G. Gogos Hot melt mixing and foaming of Soluplus® and indomethacin Polym. Eng. Sci. 52 2012 1629 1639
37. H.H. Tonnesen, M. Masson, and T. Loftsson Studies on curcumin and curcuminoids XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability Int. J. Pharm. 244 2002 127 135
38. D.W. Van Krevelen Properties of Polymers 1990 Elsevier Amsterdam pp. 189-225
39. C.L.N. Vo, C. Park, and B.J. Lee Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs Eur. J. Pharm. Biopharm. 85 2013 799 813
40. L.A. Wegiel, Y. Zhao, L.J. Mauer, K.J. Edgar, and L.S. Taylor Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability Pharm. Dev. Technol. 19 8 2014 976 986
41. J.S. Wright Predicting the antioxidant activity of curcumin and curcuminoids J. Mol. Struct. (Theochem.) 591 2002 207 217
42. M. Yoshioka, B.C. Hancock, and G. Zografi Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates J. Pharm. Sci. 84 8 1995 983 986